Last reviewed · How we verify
NCT05162339
Inflammatory Bowel Disease and Thromboembolic Events
trial testing No intervention was made in Inflammatory Bowel Diseases in 149 participants. Completed in 30 April 2020.
30 April 2020
Quick facts
| Lead sponsor | Centro Hospitalar Tondela-Viseu |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 149 |
| Start date | 1 November 2016 |
| Primary completion | 30 April 2020 |
| Estimated completion | 30 April 2020 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- No intervention was made
Conditions studied
- Inflammatory Bowel Diseases — all drugs for Inflammatory Bowel Diseases →
- Thromboembolism — all drugs for Thromboembolism →
- Coagulation Disorder — all drugs for Coagulation Disorder →
Sponsor
Centro Hospitalar Tondela-Viseu
Who can join
18 and older, any sex, with Inflammatory Bowel Diseases or Thromboembolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective was to demonstrate the existence and importance of hypercoagulability in patients with IBD, by determining the prevalence of changes in coagulation parameters and evaluating the impact of these changes on the occurrence of thromboembolic events.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Inflammatory bowel disease and thromboembolic events: a c'lot to learn.
Carvalho AC, Pinho J, Cancela E, Vieira HM, et al · · 2022 · cited 5× · PMID 35651649 · DOI 10.1177/17562848221100626
Verify or expand the search:
- PubMed search for NCT05162339
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention was made
Trials testing the same drug.
- NCT06453070 — Hasan Kalyoncu University · completed
Other recruiting trials for Inflammatory Bowel Diseases
Currently open trials in the same condition.
- NCT07520747 — A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea · recruiting
- NCT07349472 — Pentoxifylline in Patients With Ulcerative Colitis · Phase 2 · recruiting
- NCT07033208 — Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance · NA · recruiting
- NCT06842316 — Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases · recruiting
- NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting
Other Centro Hospitalar Tondela-Viseu trials
Trials by the same sponsor.
- NCT05040854 — Can we Rely on HLA to Predict Resistance to Biological Therapy in IBD Patients · unknown
- NCT05414435 — Informed Consent in Endoscopy: Read, Understood or Merely Signed? · completed
- NCT06480929 — LV Thrombus Screening in Anterior STEMI: Worth it? · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05162339 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centro Hospitalar Tondela-Viseu
- Last refreshed: 17 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05162339.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing